38 research outputs found
Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a malignant disorder of B cell origin, with low incidence in Asian populations. In this study we investigated the HLA-class I A and B allele frequencies in 87 Iranian CLL patients and 64 healthy controls using sequence specific primer-polymerase chain reaction (SSP-PCR) technique. Our results showed increased frequencies of HLA-A11:01 (p=0.02) and HLA-B35:01 (p=0.002) alleles and HLA-A11:01/B35:01 haplotype (p=0.036) and decreased frequencies of HLA-A01:01 (p=0.02), HLA-A26:01 (p=0.03), HLA-B65:01 (p=0.03) and HLA-B53:01 (p<0.00001) alleles in CLL patients compared to the control group. Classification of the patients into non-progressive and progressive groups did not reveal significant differences for the frequency of any of the HLA-A and -B alleles or haplotypes between these two subtypes. Comparison between patients with immunoglobulin heavy chain variable region genes (IGHV) mutated (n=56) and unmutated (n=31) subtypes showed a significant increase in HLA-A32:01 (p=0.05) and HLA-A33:01 (p=0.05) alleles in IGHV unmutated patients compared to IGHV mutated patients. Similarly, a higher frequency of HLA-B52:01 (p=0.037) alleles was observed in CD38+ compared with CD38- patients. Our results obtained from an Iranian population indicate that CLL is associated with distinct HLA class I alleles and haplotypes some of which are linked to disease prognostic factors.Tehran University of Medical SciencesMinistry of Health and Medical Education of IranManuscrip
Predictive Value of Risk Factors for Chronic Idiopathic Thrombocytopenic Purpura in Patients with Acute Type of Disease
BACKGROUND: Immune thrombocytopenic purpura (ITP) is an autoimmune disease in which autoantibodies react with platelet surface antigens and results in mild to severe thrombocytopenia due to decreased platelet count or inhibition of platelet production. Given the relatively high prevalence of ITP among children and the lack of standard diagnostic testing for the diagnosis of chronic disease, this study evaluated the predictive value of risk factors for chronic ITP in hospitalized patients.
METHODS: This prospective cohort study was performed on 65 children with ITP who referred to Ali Asghar and Rasool Akram Hospitals in Tehran, Iran, during the years 2017 and 2018. Relationships between different risk factors, including age of diagnosis, gender, white cell count, primary platelet count, mean platelet volume (MPV), history and type of the previous patient infection, FCG gene mutation, and type of FCG mutation with a chronic disease incidence were investigated using multiple logistic regression model.
RESULTS: Of 65 patients, 31 (47.69%) were male and 34 (52.31%) were female included in the study. Twenty-eight patients (43.08%) had acute ITP and 37 (56.92%) had chronic ITP. Frequency of FCG gene mutation in patients with chronic and acute type ITP was 16.36% and 7.27%, respectively (p = 0.51). No association was found between the history of the previous infection and its type with the chronic incidence of ITP. The multiple logistic regression model showed that three factors, including the absolute number of lymphocytes, age of diagnosis, and primary white blood cells (WBC) count were directly linked to chronic ITP. Furthermore, three factors of platelet, sex, and MPV were indirectly related to chronic ITP. In addition, the absolute number of lymphocytes, age of diagnosis and primary WBC count were significantly associated with chronic ITP. The receiver operating characteristic analysis showed that the cutoff rate of these factors was 0.31. Further analysis of these risk factors in comparison with the gold standard demonstrated that the diagnostic sensitivity and specificity of these risk factors for chronic ITP were 73.08% and their specificity was 88.57%, indicating the high importance and predictive power of these risk factors.
CONCLUSIONS: According to the results of this study, for the first time in Iran, six risk factors, including the absolute number of lymphocytes, age at diagnosis, sex, MPV level, platelet level at time of diagnosis, and primary WBC count were considered as the most important risk factors affecting the incidence of chronic ITP. Of course, more comprehensive studies can definitely lead to more comprehensive models
Necessity of reviewing in the References to handle with mistakes and disputes in Registration of Documents and Estate (The supervisory boards and the Supreme Council of Document Record)
The administrative authorities deal with the mistakes and dispute in Registration of Documents and Estate, namely, the supervisory boards and the Supreme Council, including administrative courts that play an essential and important role in the outcome of the records. In this research , the current status of these references has been investigated and the reasons their inefficiencies are: Prolongation Checking the Files Send, Ignoring the principles of independence and impartiality, Disregard of producer tools and control tools in Impartiality in the said discretion ago, Lack of access to court for reasons such as lack of attention to the principle of the right to be heard, Has been analyzed and Finally, the necessity of reviewing the jurisdiction and scope of these authorities has been concluded the most important of these is the establishment of a Supervisory Board in all Registry Units, The creation of a new authority known as the Provincial Supreme Council of Document Records in the Provincial Document Records's General Offices and delegating the current powers of the Supreme Council of Document Record to the This Council and expanding the jurisdiction and duties of the Supreme Council of Document Records established by the State Register of Property and Documents
Effect of refrigerated storage on the probiotic survival and sensory properties of milk/carrot juice mix drink
Background: There is a genuine interest in the development of probiotic
milk and juice based beverages because they are a good-vehicle to
deliver probiotic microorganisms to consumers. For this purpose, the
viability and metabolism of four probiotic strains ( Lactobacillus
acidophilus LA5, Bifidobacterium lactis BB12, L. rhamnosus and L.
plantarum ) were studied in non-fermented milk and carrot juice mix
drink. The drinks were evaluated in 5 days interval for viable cell
count, pH, acidity, sedimentation and sensory quality during
refrigerated storage at 4 \ub1 2\ubaC for up to 20 days. Results:
The results showed that all strains had good viability in milk/carrot
juice drink (88-98%), but L. acidophilus LA5 seemed more stable than
three other strains. The levels of pH and acidity were ranged 5.33-6.6
and 0.13-0.31%, respectively. The drinks inoculated with L. rhamnosus
and control (non-probiotic) showed more variation in pH and acidity.
The most sedimentation was detected in drinks inoculated with L.
rhamnosus, reaching 3.73 mL/10 mL sample. Sensory assessment indicated
lowest acceptability in control and milk/carrot juice drink inoculated
with L. rhamnosus, respectively. Conclusion: This study indicated that
some probiotic bacteria can be applied by food producers to produce
functional drinks with an increased shelf-life
Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia : association between CD38 expression and disease progression
Background: Patients with B-cell chronic lymphocytic leukemia (B-CLL) have hetero-geneous clinical courses, thus several biological parameters need to be added to the cur-rent clinical staging systems to predict disease outcome. Recent immunophenotypic stud-ies performed mainly in Western populations have demonstrated the prognostic value of CD38 and ZAP-70 expression in B-CLL.
Objectives: To investigate the expression pat-tern of a variety of membrane antigens on leukemic cells from Iranian patients with CLL and to find out if there are any differences in the expression of these markers between in-dolent and progressive groups.
Methods: In the present study, peripheral blood samples from 87 Iranian patients with B-CLL were analysed by flow cytometry.
Results: In all cases, the neoplastic cells displayed B-CLL phenotype (CD5+/CD19+/sIg+). The vast ma-jority of the cases expressed CD23, but failed to stain for CD3 or CD14. The leukemic cells of most patients expressed CD27 (84/87, 95.4%) and CD45RO (74/87, 83.9%) molecules, suggesting a memory B-cell phenotype. Comparison between the indolent (n=42) and progressive (n=37) patients revealed significantly higher frequency and inten-sity of CD38 expression in progressive group (40.5%) compared to indolent (11.9%) pa-tients (p<0.05). None of the other membrane antigens were differentially expressed in these two groups of patients. Conclusion: Our results obtained in an Asian ethnic popula-tion confirm and extend previous findings obtained from Western populations regarding the association of CD38 expression and disease progression in B-CLL.Tehran University of Medical Sciences and the Ministry of Health and Medical Education of Iran.Publishe
Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia
Background: Patients with B-cell chronic lymphocytic leukemia (B-CLL) have heterogeneous clinical courses, thus several biological parameters need to be added to the current clinical staging systems to predict disease outcome. Recent immunophenotypic studies performed mainly in Western populations
have demonstrated the prognostic value of
CD38 and ZAP-70 expression in B-CLL.
Objectives: To investigate the expression pattern of a variety of membrane antigens on leukemic cells from Iranian patients with CLL
and to find out if there are any differences in the expression of these markers between indolent and progressive groups.
Methods: In the present study, peripheral blood samples
from 87 Iranian patients with B-CLL
were analysed by flow cytometry.
Results: In all cases, the neoplastic cells displayed B-CLL phenotype (CD5+/CD19+/sIg+). The vast majority of the cases expressed CD23, but failed to stain for CD3 or CD14. The leukemic
cells of most patients expressed
CD27 (84/87, 95.4%) and CD45RO (74/87, 83.9%)
molecules, suggesting a memory B-cell phenotype. Comparison between the indolent
(n=42) and progressive (n=37) patients revealed significantly higher frequency and intensity of CD38 expression in progressive group (40.5%) compared to indolent (11.9%) patients (p<0.05). None of the other membrane antigens were differentially expressed in
these two groups of patients.
Conclusion: Our results obtained in an Asian ethnic population confirm and extend previous findings obtained from Western populations regarding the association of CD38 expression and disease progression in B-CLL.Tehran University of Medical sciences, Tehran, IranPublishe
Comparative expression profile of orphan receptor tyrosine kinase ROR1 in Iranian patients with lymphoid and myeloid leukemias
It has recently been shown that ROR1, a member of the receptor tyrosine kinase family, is overexpressed in leukemic B cells of Chronic Lymphocytic Leukemia (CLL) and a subset of Acute Lymphoblastic Leukemia (ALL). In this comparative study the expression profile of ROR1 mRNA was investigated in Iranian patients with CLL and Acute Myelogenous Leukemia (AML) and the results were compared with those previously reported in our Iranian ALL patients. RT-PCR was performed on bone marrow and/or peripheral blood samples of 84 CLL and 12 AML patients. CLL samples were classified into immunoglobulin heavy chain variable region (IGHV) gene mutated (n = 55) and unmutated (n = 29) and also indolent (n = 42) and progressive (n = 39) subtypes. ROR1 expression was identified in 94% of our CLL patients, but none of the AML patients expressed ROR1. No significant differences were observed between different CLL subtypes for ROR1 expression. Taken together the present data and our previous results on ROR1 expression in ALL, our findings propose ROR1 as a tumor-associated antigen overexpressed in a large proportion of lymphoid (CLL and ALL), but not myeloid (AML) leukemias. Expression of ROR1 seems to be associated to lineage and differentiation stages of leukemic cells with a potential implication for immunotherapy.Tehran University of Medical SciencesPublishe
Comparative expression profile of orphan receptor tyrosine kinase ror1 in iranian patients with lymphoid and myeloid leukemias
It has recently been shown that ROR1, a member of the receptor tyrosine
kinase family, is overexpressed in leukemic B cells of Chronic Lymphocytic
Leukemia (CLL) and a subset of Acute Lymphoblastic Leukemia (ALL). In this
comparative study the expression profile of ROR1 mRNA was investigated in
Iranian patients with CLL and Acute Myelogenous Leukemia (AML) and the
results were compared with those previously reported in our Iranian ALL
patients. RT-PCR was performed on bone marrow and/or peripheral blood
samples of 84 CLL and 12 AML patients. CLL samples were classified into immunoglobulin
heavy chain variable region (IGHV) gene mutated (n=55) and
unmutated (n=29) and also indolent (n=42) and progressive (n=39) subtypes.
ROR1 expression was identified in 94% of our CLL patients, but none of the
AML patients expressed ROR1. No significant differences were observed between
different CLL subtypes for ROR1 expression. Taken together the present
data and our previous results on ROR1 expression in ALL, our findings propose
ROR1 as a tumor-associated antigen overexpressed in a large proportion of
lymphoid (CLL and ALL), but not myeloid (AML) leukemias. Expression of
ROR1 seems to be associated to lineage and differentiation stages of leukemic
cells with a potential implication for immunotherapy.Tehran University of Medical Sciences and the Ministry of Health and Medical Education of Iran.Publishe
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of AlvotereⓇ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy
Background
Docetaxel is a clinically well established antimitotic chemotherapy medication. Labeled docetaxel indications are breast cancer, gastric cancer, head and neck cancer, non–small cell lung cancer, and prostate cancer.
Objective
This is a Phase IV study to evaluate the safety profile of docetaxel (Alvotere; NanoAlvand, Iran) in Iranian patients diagnosed with different types of cancers receiving chemotherapy regimens with docetaxel.
Methods
Patients who received Alvotere as a part of their chemotherapy regimen were enrolled in this Phase IV, observational, multicenter, open-label study. Alvotere was administrated as a single agent or in combination with other chemotherapy agents. Safety parameters in each cycle were assessed, and the related data were recorded in booklets.
Findings
A total of 411 patients with different types of cancers were enrolled from 25 centers in Iran. The most common malignancies among participants were breast cancer (49.88%), followed by gastric cancer (22.63%). Participants’ mean age was 53.33 years, and the mean total dose used in each cycle was 132 mg. According to the results, 341 patients experienced at least 1 adverse event, that the most common was alopecia (41.12%). In total, 92 (22.38%) patients had at least 1 adverse event of grade 3 or 4, and 25 (6.08%) patients showed 54 serious adverse events, which the causality assessment for all was possibly related to Alvotere. There was a significant difference between men and women in the incidence of skin and subcutaneous tissue disorders (55.63% in women vs 41.73% in men; P = 0.009). Also, the incidence of gastrointestinal disorders, nervous system disorders, skin and subcutaneous tissue disorders, hepatic enzymes increase, and fluid retention was significantly higher (P < 0.05) in patients receiving anthracyclines in their chemotherapy regimens.
Conclusions
The findings of this open-label, observational, multicenter, postmarketing surveillance showed that Alvotere appears to have an acceptable safety profile in Iranian cancer patients receiving chemotherapeutic regimens. (Curr Ther Res Clin Exp. 2022; 82:XXX–XXX) © 2022 Elsevier HS Journals, Inc